Colossal Biosciences is a biotechnology company that applies genomic engineering, synthetic biology, and advanced conservation science to ambitious de‑extinction and species‑rescue initiatives. Founded in 2021, Colossal Biosciences is notable for integrating high‑throughput CRISPR, comparative genomics, and translational breeding strategies to restore genetic diversity and pursue large‑scale conservation projects that bridge commercial biotech capabilities with ecological stewardship.
EN